Literature DB >> 17695505

Effect of copper and role of the copper transporters ATP7A and CTR1 in intracellular accumulation of cisplatin.

Shinobu Matsumoto1, Toshiko Tanaka, Hideo Kurokawa, Koji Matsuno, Yutaka Hayashida, Tetsu Takahashi.   

Abstract

An investigation was carried out as to whether copper affected the intracellular accumulation of cisplatin (cis-diamminedichloroplatinum(II); CDDP) and whether changes in the expression of ATP7A and CTR1 were related to acquired resistance using CDDP-sensitive (KB) and -resistant (KBR/0.8, KBR/1.2) cells. Intracellular platinum accumulation and platinum-DNA adducts were significantly lower in the CDDP-resistant sublines compared with KB cells. Treatment with 750 microM CuSO4 increased the amount of intracellular platinum 1.8-, 3.2-, and 3.9-fold in KB, KBR/0.8, and KBR/1.2 cells respectively, and increased the platinum-DNA adducts by 1.9-fold in KB cells and by 3.2-fold in KBR/1.2 cells. The level of ATP7A was greatly reduced and CTR1 expression slightly decreased in KBR/1.2 cells compared with KB cells. ATP7A expression was markedly increased by exposure to CDDP with or without copper in KB cells but not in KBR/1.2 cells. CDDP and copper did not increase the level of CTR1 in KB or KBR/1.2 cells. These results indicate that a high concentration of copper causes a significant increase in the cellular accumulation of CDDP and binding of platinum to DNA independently of CTR1 expression in KB cells and CDDP-resistant sublines thereof and that the acquisition of CDDP resistance is associated with a greatly reduced level of ATP7A and a marginally lower expression of CTR1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17695505

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

Review 1.  Contribution of tumoral and host solute carriers to clinical drug response.

Authors:  Jason A Sprowl; Torben S Mikkelsen; Hugh Giovinazzo; Alex Sparreboom
Journal:  Drug Resist Updat       Date:  2012-03-28       Impact factor: 18.500

Review 2.  Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.

Authors:  Stephen B Howell; Roohangiz Safaei; Christopher A Larson; Michael J Sailor
Journal:  Mol Pharmacol       Date:  2010-02-16       Impact factor: 4.436

Review 3.  Polymorphic transporters and platinum pharmacodynamics.

Authors:  Jason A Sprowl; Rachel A Ness; Alex Sparreboom
Journal:  Drug Metab Pharmacokinet       Date:  2012-09-18       Impact factor: 3.614

Review 4.  Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.

Authors:  Rogerio M Castilho; Cristiane H Squarize; Luciana O Almeida
Journal:  Int J Mol Sci       Date:  2017-07-12       Impact factor: 5.923

5.  The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells.

Authors:  Serena Pillozzi; Massimo D'Amico; Gianluca Bartoli; Luca Gasparoli; Giulia Petroni; Olivia Crociani; Tiziano Marzo; Angela Guerriero; Luigi Messori; Mirko Severi; Roberto Udisti; Heike Wulff; K George Chandy; Andrea Becchetti; Annarosa Arcangeli
Journal:  Br J Cancer       Date:  2017-11-21       Impact factor: 7.640

Review 6.  The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets.

Authors:  Si Sun; Jing Cai; Qiang Yang; Simei Zhao; Zehua Wang
Journal:  Oncotarget       Date:  2017-02-28

7.  Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In Vitro Approach.

Authors:  Mohamed R Abdelaal; Esraa Ibrahim; Mohamed R Elnagar; Sameh H Soror; Hesham Haffez
Journal:  Int J Mol Sci       Date:  2022-08-21       Impact factor: 6.208

8.  Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity.

Authors:  Verena Pichler; Petra Heffeter; Seied M Valiahdi; Christian R Kowol; Alexander Egger; Walter Berger; Michael A Jakupec; Mathea Sophia Galanski; Bernhard K Keppler
Journal:  J Med Chem       Date:  2012-12-17       Impact factor: 7.446

9.  Uptake of compounds that selectively kill multidrug-resistant cells: the copper transporter SLC31A1 (CTR1) increases cellular accumulation of the thiosemicarbazone NSC73306.

Authors:  King Leung Fung; Abisola K Tepede; Kristen M Pluchino; Lynn M Pouliot; Jessica N Pixley; Matthew D Hall; Michael M Gottesman
Journal:  Mol Pharm       Date:  2014-06-17       Impact factor: 4.939

10.  Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.

Authors:  Minghan Shi; Malathi Anantha; Mohamed Wehbe; Marcel B Bally; David Fortin; Laurent-Olivier Roy; Gabriel Charest; Maxime Richer; Benoit Paquette; Léon Sanche
Journal:  J Nanobiotechnology       Date:  2018-10-05       Impact factor: 10.435

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.